Response post first autologous stem cell transplantation (ASCT) for multiple myeloma identify patients who may benefit from tandem transplants: A single center prospective phase II study

被引：0
|
作者：
Moreb, Jan S. [1 ]
Salmasinia, Donya [1 ]
Leather, Helen [1 ]
Davis, Amy [1 ]
Hsu, Jack [1 ]
Wiggins, Laura [1 ]
Cogle, Christopher R. [1 ]
Chang, Myron N. [1 ]
Wingard, John R. [1 ]
机构：
[1] Univ Florida, Gainesville, FL USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-4618
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4618
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Outcome of African-American (AA) Multiple Myeloma (MM) Patients after Autologous Stem Cell Transplantation (ASCT): A Single-Center Experience
    Wu, Yin
    Goloubeva, Olga
    Ruehle, Kathleen
    Yanovich, Saul
    Rapoport, Aaron P.
    Akpek, Gorgun
    Badros, Ashraf Z.
    BLOOD, 2008, 112 (11) : 1143 - 1143
  • [22] Full dose or reduced dose Melphalan (MEL) for autologous stem cell transplantation (ASCT) in multiple myeloma (MM): a single center analysis on 146 patients
    vom Hofe, F.
    Muegge, L-O
    Scholl, S.
    Hilgendorf, I
    Sayer, H.
    Yomade, O.
    Ernst, T.
    Hochhaus, A.
    von Lilienfeld-Toal, M.
    Brioli, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 184 - 184
  • [23] AUTOLOGOUS STEM CELL TRANSPLANTATION AND MAINTENANCE TREATMENT IN MULTIPLE MYELOMA PATIENTS. A SINGLE CENTER EXPERIENCE
    Bilalis, A.
    Soupos, N.
    Sioni, A.
    Stefanitsi, P.
    Tsirogianni, M.
    Zina, V.
    Pouli, A.
    Tsakanikas, S.
    Papanastasiou, K.
    Stamatelou, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 620 - 620
  • [24] Efficacy and safety of autologous hematopoietic stem cell transplantation in elderly multiple myeloma patients:a single center retrospective study
    黄蓓晖
    ChinaMedicalAbstracts(InternalMedicine), 2022, 39 (02) : 120 - 120
  • [25] A phase II, single-arm, prospective study of bendamustine plus melphalan conditioning for second autologous stem cell transplantation in de novo multiple myeloma patients through a tandem transplant strategy
    M Martino
    G Tripepi
    G Messina
    I D Vincelli
    G Console
    A G Recchia
    M Gentile
    S Molica
    F Morabito
    Bone Marrow Transplantation, 2016, 51 : 1197 - 1203
  • [26] A phase II, single-arm, prospective study of bendamustine plus melphalan conditioning for second autologous stem cell transplantation in de novo multiple myeloma patients through a tandem transplant strategy
    Martino, M.
    Tripepi, G.
    Messina, G.
    Vincelli, I. D.
    Console, G.
    Recchia, A. G.
    Gentile, M.
    Molica, S.
    Morabito, F.
    BONE MARROW TRANSPLANTATION, 2016, 51 (09) : 1197 - 1203
  • [27] Double autologous haematopoietic stem cell transplantation for multiple myeloma - a prospective single-centre study
    Nemet, D
    Sertic, D
    Kovacevic-Metelko, J
    Bogdanic, V
    Mrsic, M
    Bojanic, I
    Batinic, D
    Golubic-Cepulic, B
    Serventi-Seiwerth, R
    Radman, I
    Aurer, I
    Zupancic-Salek, S
    Durakovic, N
    Lausin, I
    Mikulic, M
    Labar, B
    BONE MARROW TRANSPLANTATION, 2005, 35 : S252 - S252
  • [28] Early response-based intensification of primary therapy in newly diagnosed multiple myeloma patients who are eligible for autologous stem cell transplantation: phase II study
    Seo-Yeon Ahn
    Sung-Hoon Jung
    Young Don Joo
    Won Sik Lee
    Sang Min Lee
    Chul Won Choi
    Seok Jin Kim
    Kihyun Kim
    Je-Jung Lee
    Annals of Hematology, 2014, 93 : 1571 - 1577
  • [29] Early response-based intensification of primary therapy in newly diagnosed multiple myeloma patients who are eligible for autologous stem cell transplantation: phase II study
    Ahn, Seo-Yeon
    Jung, Sung-Hoon
    Joo, Young Don
    Lee, Won Sik
    Lee, Sang Min
    Choi, Chul Won
    Kim, Seok Jin
    Kim, Kihyun
    Lee, Je-Jung
    ANNALS OF HEMATOLOGY, 2014, 93 (09) : 1571 - 1577
  • [30] OUTCOME OF AUTOLOGOUS STEM CELLS TRANSPLANTATION (ASCT) IN COMPARISON WITH NEW DRUG-BASED REGIMENS AS SALVAGE TREATMENT AFTER FIRST LINE THERAPY WITH SINGLE OR TANDEM ASCT IN MULTIPLE MYELOMA PATIENTS
    Crippa, C.
    Ferrari, S.
    Drera, M.
    Roccaro, A.
    Baushi, L.
    Antoniazzi, F.
    Rossi, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 152 - 153
12345